Target intelligence / Profile preview

Sin3 histone deacetylase complex (SIN3-HDAC complex)

Target
SIN3-HDAC complex
Molecular classification
Chromatin modifier, Histone deacetylase complex, Transcriptional co-regulator, Epigenetic regulator, Multi-protein complex
01

Overview

The Sin3 histone deacetylase complex (often called the SIN3-HDAC complex) is a ubiquitous, conserved, multi-protein chromatin-modifying complex involved in the regulation of gene expression through histone deacetylation. It acts as a scaffold for the assembly of histone deacetylases (primarily HDAC1 and HDAC2), transcription factors, and chromatin adaptor proteins, thus functioning as both a co-repressor and, in some contexts, a co-activator of gene transcription[1][3][5]. The complex can be subdivided into at least two forms (SIN3L, SIN3S), which differ in protein composition and chromatin targeting, allowing the complex to participate in regulation of both promoter and gene body chromatin[5]. Sin3 complexes play critical roles in mammalian development, maintenance of stem cell pluripotency, cell cycle progression, apoptosis, and are implicated in the pathogenesis of numerous cancers by regulating key genes involved in cell proliferation and differentiation[1][3][5]. Therapeutically, the SIN3-HDAC complex is targeted indirectly by histone deacetylase inhibitors, which inhibit the catalytic subunits, leading to global changes in chromatin structure and gene expression. Safety and biomarker strategies focus on the degree of histone acetylation and transcriptional response as indirect readouts for complex inhibition.

Other names
Sin3/HDAC complexSIN3 complexSin3A/HDAC1 complexSIN3 co-repressor complexSIN3 large (SIN3L) and SIN3 small (SIN3S) complexes
02

Mechanism of action

Inhibitors targeting the HDAC enzymatic subunits (e.g., HDAC1/2) prevent histone deacetylation, resulting in increased histone acetylation, relaxed chromatin structure, and altered gene expression[1][3][4][5].

03

Biological functions

Regulation of gene expressionChromatin remodelingTranscriptional repressionTranscriptional activationCell cycle regulationCell proliferationCell differentiationApoptosisMaintenance of pluripotencyMammalian development
04

Disease associations

CancerDevelopmental disordersPotential roles in neurodegenerative disease (less well established)Other diseases involving epigenetic dysregulation
05

Safety considerations

Broad inhibition of HDACs can result in toxicity, including hematologic, gastrointestinal, and cardiac adverse effects (effects may be due to pan-HDAC inhibition, not SIN3-HDAC specifically)Epigenetic changes can be pleiotropic and unpredictable, leading to off-target effects
06

Interacting drugs

Histone deacetylase (HDAC) inhibitors (e.g., vorinostat, panobinostat, romidepsin target the HDAC subunits, especially HDAC1/2, within the complex)
07

Biomarkers

Acetylation levels of histones (as an indirect pharmacodynamic marker)Expression of target genes regulated by SIN3-HDACReduced expression of SIN3-HDAC complex subunits may be associated with cancer outcome (context-dependent; not a validated biomarker for patient selection)

Beyond the preview

Go deeper on Sin3 histone deacetylase complex (SIN3-HDAC complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sin3 histone deacetylase complex (SIN3-HDAC complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call